About Medlius
Medlius is a Healthcare company founded in 2017. It operates as a pharmaceutical products and healthcare solutions focused on womens health and nutritional supplements in India. Its Indian entity Medlius Pharma Private Limited reported revenue of ₹3.95 Cr. Medlius offers products and services including Ferofag and Calzup+. Its focus areas include Nutritional Supplements, Vitamins and Minerals, Daily Supplements and Pharmaceuticals.
Company details
Medlius was established in 2017 in Maharashtra, India, with a commitment to delivering affordable and high-quality healthcare solutions. Products for womens health, nutritional supplements, pain management, and digestive health are provided, aiming to enhance quality of life. Expansion to Western and Northern India has been achieved, while maintaining focus on innovation and accessibility. A team of dedicated professionals ensures that healthcare needs are met through reliable offerings, supporting individuals in achieving better health outcomes.
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Social LinkedIn Facebook Instagram
- Legal Name Medlius Pharma Pvt. Ltd
- Date of Incorporation 17 Jun, 2019
- Jurisdiction Kharadi, Maharashtra, India
- Annual Revenue₹3.95 Cr
FY 2025 · +16% YoY
- Net Loss-₹1.29 Cr
FY 2025 · -33% margin
- EBITDA-₹1.27 Cr
FY 2025 · -32% margin
Associated legal entities of Medlius
Medlius operates through Medlius Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Medlius Pharma Private Limited CIN U51397PN2019PTC184834 | Active | 17 Jun 2019 | Kharadi, Maharashtra | ₹4.0 Cr | – | 2 | View details |
Products & Services of Medlius
Medlius offers a comprehensive portfolio of products and services, including Ferofag and Calzup+.
A product for pregnancy and lactation needs is offered to support maternal and child health.
Supplements for bone and joint health are provided to address vitamin deficiencies and promote overall wellness.
Board of directors of Medlius Pharma Private Limited (Medlius)
Medlius Pharma Private Limited is the primary company behind Medlius. The board of Medlius Pharma Private Limited currently have 2 directors; the longest-serving is Aakash Goyal, appointed in 2023. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Aakash Goyal DIN 07623993 | Director | 27 Jan 2023 | 3 yrs 8 mo | Medlius Pharma Private Limited |
| Ajay Goel DIN 00203434 | Director | 20 May 2025 | 1 yr 5 mo | Medlius Pharma Private Limited |
Financials of Medlius
Figures of Medlius Pharma Private Limited, the primary company behind Medlius, for FY 2025. Revenue was ₹3.95 Cr (+16% year on year). Net loss was -₹1.29 Cr (-33% margin). EBITDA was -₹1.27 Cr (-32% margin). Revenue has grown at a compounded annual rate of +6% over three years and -6% over five years.
- ₹3.95 CrRevenue · FY 2025 · +16% YoY
- -₹1.29 CrNet loss · -33% margin
- -₹1.27 CrEBITDA · -32% margin
- ₹10 LakhPaid-up capital
- +6%Revenue CAGR, 3 years
- -6%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Medlius Pharma Private Limited are on its company page.
Detailed financial statements for Medlius
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Top companies in Traditional Health & Nutrition
10 companies that operate in the same segment as Medlius (Traditional Health & Nutrition), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | – | USD 3.02 B | 8,300 | |
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Oral solid drug delivery systems are manufactured and developed. | 1985 | Mumbai, Maharashtra, India | USD 42.49 M | USD 89.42 M | 962 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | – | USD 5.1 B | 13,500 | |
Generic pharmaceuticals are manufactured by Teva Pharmaceuticals. | 1901 | Petah Tikva, Central District, Israel | USD 500 M | USD 18.74 B | 51,792 | |
Generic, semi-solid, and liquid dosage forms are manufactured. | 1990 | Bengaluru, Karnataka, India | – | USD 508.93 M | 5,180 | |
Pharmaceutical products are developed and marketed globally. | 2009 | Montville, New Jersey, United States | USD 155.92 M | – | – | |
Specialty generic pharmaceuticals and APIs are manufactured and marketed. | 1983 | Mumbai, Maharashtra, India | – | USD 6.21 B | 25,870 | |
Pharmaceutical company engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations | 1991 | Delhi, Delhi, India | USD 367.2 M | USD 1.52 B | 21,320 | |
Generics, biosimilars, APIs, and vaccines are manufactured by Wockhardt. | 1967 | Mumbai, Maharashtra, India | – | USD 353.53 M | 3,410 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Medlius
Medlius was founded in 2017.
The primary company behind Medlius, Medlius Pharma Private Limited, reported revenue of ₹3.95 Cr for FY 2025, up 16% year on year.
Medlius was established in 2017 in Maharashtra, India, with a commitment to delivering affordable and high-quality healthcare solutions. Products for womens health, nutritional supplements, pain management, and digestive health are provided, aiming to enhance quality of life. Expansion to Western and Northern India has been achieved, while maintaining focus on innovation and accessibility. A team of dedicated professionals ensures that healthcare needs are met through reliable offerings, supporting individuals in achieving better health outcomes.
Medlius offers Ferofag and Calzup+.
Medlius operates through Medlius Pharma Private Limited.
The legal entities of Medlius currently have 2 directors, including Aakash Goyal, Ajay Goel.